Detalhe da pesquisa
1.
Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: An HCV-TARGET analysis.
Hepatology;
76(2): 483-491, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35034373
2.
Sustainable and equivalent improvements in symptoms and functional well-being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial.
J Viral Hepat;
29(9): 795-806, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35657133
3.
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Hepatology;
74(6): 2952-2964, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34255381
4.
Linkage of resistance-associated substitutions in GT1 sofosbuvir + NS5A inhibitor failures treated with glecaprevir/pibrentasvir.
J Hepatol;
75(4): 820-828, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34023351
5.
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy.
Gastroenterology;
157(6): 1506-1517.e1, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31401140
6.
Hepatitis C virus: how to provide the best treatment with what I have.
Liver Int;
36 Suppl 1: 58-61, 2016 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26725898
7.
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.
J Hepatol;
62(2): 286-93, 2015 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25218788
8.
Optimal interferon-free therapy in treatment-experienced chronic hepatitis C patients.
Liver Int;
35 Suppl 1: 65-70, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25529089
9.
Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.
Gastroenterology;
153(3): 626-631, 2017 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28757271
10.
New therapeutic strategies in HCV: second-generation protease inhibitors.
Liver Int;
33 Suppl 1: 80-4, 2013 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23286850
11.
Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection.
Sci Rep;
12(1): 18094, 2022 10 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36302828
12.
Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial.
Hepatology;
50(6): 1818-26, 2009 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19824078
13.
Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.
Sci Rep;
8(1): 3199, 2018 02 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29453451
14.
Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin.
Hepatology;
36(4 Pt 1): 967-72, 2002 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12297845